Anca-associated Vasculitis
📧 Sign up to get email alerts when something new happens for Anca-associated Vasculitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating QT-019C, a CD19 and BCMA-targeted CAR T-cell therapy, for relapse/refractory autoimmune diseases; recrui…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases [NA]
This clinical trial is recruiting to evaluate anti-CD19 IL-10/IL-15 CAR-NK cells for refractory/relapsed autoimmune diseases. Conditions inc…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases [NA]
A clinical trial update evaluating CD19 UCAR-T cell therapy in autoimmune diseases; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
This clinical trial aims to characterize autoreactive B lymphocytes in autoimmune diseases and immune deficiencies. The study status is not …
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: (68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis
A clinical trial evaluating the use of Gallium-68 labeled FAPI PET/CT imaging for ANCA-associated vasculitis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases [Phase 1, Phase 2]
An open-label Phase 1/2 study evaluating povetacicept in autoantibody-associated glomerular diseases is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. [EARLY_Phase 1]
Phase 1 study evaluating anti-CD19/BCMA universal CAR-T cell therapy RD06-05 in autoimmune diseases; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update assessing a dual CD19/BCMA-targeted CAR T-cell therapy for relapse/refractory autoimmune diseases, currently r…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
This clinical trial update describes ongoing research in safety and efficacy assessment for rheumatologic diseases and related conditions, w…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC) [Phase 2]
This update describes a Phase 2 clinical trial (SPARVASC) examining ETA receptor antagonism and AT1 receptor antagonism in ANCA-associated v…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases [Phase 1, Phase 2]
This clinical trial update describes a phase 1/2 study evaluating universal CD19-targeting CAR-γδT cells for refractory autoimmune diseases,…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Clinical trial update describing the EACVI study on multimodality cardiovascular imaging for inflammatory cardiovascular diseases, with myoc…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 cell therapy for relapsed/refractory autoimmune diseases is currently recruiting. The study cover…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis [Phase 4]
Phase 4 clinical trial evaluating the impact of SGLT-2 inhibitors on albuminuria in chronic kidney disease patients with lupus nephritis and…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: The Safety, Efficacy, and Cellular Metabolic Kinetics of CT1192 in Treating Patients With Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis [Phase 1]
Phase 1 clinical trial evaluating CT1192 for safety, efficacy, and cellular metabolic kinetics in ANCA-associated vasculitis; the study stat…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases [Phase 1]
Phase 1 clinical trial evaluating a BCMA/CD19 dual-targeted CAR-T cell therapy for autoimmune kidney diseases, currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
A clinical trial update from Assistance Publique - Hôpitaux de Paris describes a study on epithelial dysmetabolism and renal fibrosis in ANC…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis [NA]
A completed clinical trial from University Hospital, Bordeaux investigates the role of soluble CD95 ligand in the pathophysiology of ANCA-as…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV [EARLY_Phase 1]
This update covers an early-phase Phase 1 trial of RD06-04, a targeted CD19 universal CAR-T cell therapy, for idiopathic inflammatory myopat…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating OL-108 in relapsed/refractory autoimmune diseases is currently recruiting, including systemic lupus erythematosus…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update for UCAR T-cell therapy targeting CD19/BCMA in relapse/refractory autoimmune diseases. The study includes seve…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial [Phase 3]
A Phase 3 clinical trial (RENATO) evaluating pioglitazone to promote renal tolerance in ANCA-associated vasculitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis [Phase 4]
This update describes a Phase 4 trial evaluating avacopan versus reduced-dose glucocorticoids in ANCA-associated vasculitis, which is curren…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases [Phase 1, Phase 2]
Clinical trial update for anti-CD19 CAR T-cell therapy being explored in refractory systemic autoimmune diseases, including systemic lupus e…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: AYLo - AutoimmunitY and Loss of y
Clinical trial AYLo from the University of Bonn investigates autoimmunity across multiple diseases and is currently recruiting.